Alphamab Oncology

Jun 08, 2020

Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer

Apr 16, 2020

Alphamab Oncology Received U.S. FDA IND Approval to Initiate A Phase II Clinical Trial of KN046 For NSCLC in the United States

Mar 30, 2020

Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China